Lifecore Biomedical, Inc. De (LFCR) Current Leases (2019 - 2025)

Lifecore Biomedical has reported Current Leases for 7 years, with the latest figure at $4.0 million in Q1 2025.

• On a quarterly basis, Current Leases fell 4.64% year-over-year to $4.0 million in Q1 2025; TTM through Feb 2025 was $4.0 million, a 4.64% decrease from a year earlier, with the FY2024 full-year figure at $4.0 million, up 212.05% from the prior year.
• Current Leases was $4.0 million for Q1 2025 at Lifecore Biomedical, down from $4.1 million in the prior quarter.
• The five-year high for Current Leases was $4.4 million in Q1 2022, with the low at $977000.0 in Q2 2021.
• Average Current Leases over 5 years is $2.8 million, with a median of $4.0 million recorded in 2024.
• The sharpest annual moves came in 2021 and 2022: Current Leases sank 77.91% in 2021, then soared 347.08% in 2022.
• Over 5 years, Current Leases stood at $1.2 million in 2021, then jumped by 255.83% to $4.3 million in 2022, then plunged by 72.47% to $1.2 million in 2023, then surged by 245.01% to $4.1 million in 2024, then dropped by 3.64% to $4.0 million in 2025.
• The last three Current Leases figures came in at $4.0 million (Q1 2025), $4.1 million (Q4 2024), and $4.1 million (Q3 2024), per Business Quant data.